Hepatotoxicity associated with ribociclib among breast cancer patients

Authors

  • Stefania Finnsdottir Faculty of Medicine, University of Iceland, Reykjavik, Iceland
  • Asgerdur Sverrisdottir Department of Oncology, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
  • Einar S. Björnsson Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland

DOI:

https://doi.org/10.1080/0284186X.2020.1853228

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2021-02-01

How to Cite

Finnsdottir, S., Sverrisdottir, A., & Björnsson, E. S. (2021). Hepatotoxicity associated with ribociclib among breast cancer patients. Acta Oncologica, 60(2), 195–198. https://doi.org/10.1080/0284186X.2020.1853228

Issue

Vol. 60 No. 2 (2021): Acta Oncologica

Section

Articles